Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $8.53 and traded as high as $8.69. Hypera shares last traded at $8.57, with a volume of 1,268 shares trading hands.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group raised Hypera from a "neutral" rating to a "buy" rating in a report on Monday, October 17th.

Hypera Stock Up 6.0 %

The firm has a fifty day moving average of $8.56 and a 200 day moving average of $8.01.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

Read More

• Get a free copy of the StockNews.com research report on Hypera (HYPMY)
• McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
• Can Comcast Monetize Existing Users for Streaming Success?
• Chevron Gushes More Profits; Is it Time for Investors to Buy?
• Why is Amazon Stock Falling? Is the Sell-Off Overdone?
• Will Ryanair Stock Gains, Strong Estimates Help it Fly?

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.